EP 1404369 A1 20040407 - COMPOSITION COMPRISING A PDE-4 INHIBITOR AND H1-RECEPTOR ANTAGONIST AND THE USE THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF RESPIRATORY DISEASES
Title (en)
COMPOSITION COMPRISING A PDE-4 INHIBITOR AND H1-RECEPTOR ANTAGONIST AND THE USE THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF RESPIRATORY DISEASES
Title (de)
ZUSAMMENSETZUNG MIT EINEM PDE-4-INHIBITOR UND H1-REZEPTOR-ANTAGONIST UND IHRE VERWENDUNG BEI DER HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN
Title (fr)
COMPOSITION CONTENANT UN INHIBITEUR DE PDE-4 ET UN ANTAGONISTE DU RECEPTEUR H1 ET UTILISATION DE CETTE COMPOSITION DANS LA FABRICATION D'UN MEDICAMENT DESTINE AU TRAITEMENT DE MALADIES RESPIRATOIRES
Publication
Application
Priority
- GB 0202679 W 20020617
- GB 0115181 A 20010620
Abstract (en)
[origin: WO03000289A1] This invention relates to treating pulmonary diseases such as chronic obstructive pulmonary disease or asthma by administering a phosphodiesterase 4 inhibitor in combination with an H1 -receptor antagonist.
IPC 1-7
A61K 45/06; A61K 31/192; A61K 31/4545; A61K 31/44; A61K 31/4439; A61K 31/454; A61K 31/451; A61K 31/445; A61P 11/06; A61P 11/08
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/72 (2006.01); A61K 31/277 (2006.01); A61K 31/404 (2006.01); A61K 31/4409 (2006.01); A61K 31/445 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); C07D 211/22 (2006.01); A61P 11/06 (2006.01); A61P 11/08 (2006.01); A61P 43/00 (2006.01); C07D 209/40 (2006.01); C07D 211/64 (2006.01); C07D 213/75 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP KR US)
A61K 31/4545 (2013.01 - KR); A61K 45/06 (2013.01 - EP US); A61P 11/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 11/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Citation (examination)
- EP 1005865 A1 20000607 - PANACEA BIOTEC LTD [IN]
- ANDRI ET AL: "Combined treatment of allergic rhinitis with terfenadine and nimesulide, a non-steroidal antiinflammatory drug", ALLERGIE AND IMMUNOLOGIE, vol. 24, no. 8, 1992, pages 313 - 319
- See also references of WO 03000289A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03000289 A1 20030103; AR 035253 A1 20040505; BR 0210473 A 20040810; CA 2450758 A1 20030103; CN 1518460 A 20040804; CO 5540290 A2 20050729; CZ 20033435 A3 20040818; EP 1404369 A1 20040407; GB 0115181 D0 20010815; HU P0400222 A2 20040728; HU P0400222 A3 20060228; IL 159379 A0 20040601; JP 2005501023 A 20050113; KR 20040029323 A 20040406; MX PA03011702 A 20040319; NO 20035602 D0 20031216; PL 367622 A1 20050307; RU 2004101278 A 20050227; US 2004176419 A1 20040909; ZA 200309587 B 20050223
DOCDB simple family (application)
GB 0202679 W 20020617; AR P020102327 A 20020620; BR 0210473 A 20020617; CA 2450758 A 20020617; CN 02812473 A 20020617; CO 03110315 A 20031217; CZ 20033435 A 20020617; EP 02735611 A 20020617; GB 0115181 A 20010620; HU P0400222 A 20020617; IL 15937902 A 20020617; JP 2003506932 A 20020617; KR 20037016676 A 20031219; MX PA03011702 A 20020617; NO 20035602 A 20031216; PL 36762202 A 20020617; RU 2004101278 A 20020617; US 48096903 A 20031208; ZA 200309587 A 20031210